Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Long Noncoding | 5 | 2021 | 208 | 1.430 |
Why?
|
| MicroRNAs | 7 | 2021 | 829 | 1.130 |
Why?
|
| Gene Regulatory Networks | 4 | 2018 | 352 | 1.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2018 | 1872 | 0.950 |
Why?
|
| RNA, Neoplasm | 1 | 2018 | 138 | 0.590 |
Why?
|
| Sequence Analysis, RNA | 3 | 2023 | 375 | 0.550 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2022 | 861 | 0.530 |
Why?
|
| Neoplasms | 3 | 2019 | 2758 | 0.490 |
Why?
|
| Computational Biology | 4 | 2014 | 804 | 0.480 |
Why?
|
| Epistasis, Genetic | 1 | 2014 | 91 | 0.460 |
Why?
|
| RNA Interference | 2 | 2014 | 496 | 0.430 |
Why?
|
| RNA, Messenger | 2 | 2021 | 2815 | 0.330 |
Why?
|
| Gene Expression Profiling | 5 | 2023 | 1680 | 0.300 |
Why?
|
| Urinary Catheterization | 1 | 2024 | 81 | 0.230 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2024 | 16 | 0.230 |
Why?
|
| RNA, Untranslated | 2 | 2021 | 111 | 0.220 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 3285 | 0.210 |
Why?
|
| Catheter-Related Infections | 1 | 2024 | 131 | 0.210 |
Why?
|
| Machine Learning | 1 | 2024 | 220 | 0.200 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 240 | 0.190 |
Why?
|
| Urinary Tract Infections | 1 | 2024 | 295 | 0.180 |
Why?
|
| Transcriptome | 2 | 2023 | 903 | 0.170 |
Why?
|
| Oncogenes | 2 | 2018 | 168 | 0.160 |
Why?
|
| Vaccination | 1 | 2024 | 947 | 0.160 |
Why?
|
| Sequence Analysis, Protein | 3 | 2008 | 49 | 0.160 |
Why?
|
| Databases, Genetic | 2 | 2018 | 470 | 0.150 |
Why?
|
| Subcellular Fractions | 2 | 2008 | 98 | 0.150 |
Why?
|
| Genital Neoplasms, Female | 1 | 2018 | 46 | 0.140 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 334 | 0.140 |
Why?
|
| Microbiota | 1 | 2022 | 391 | 0.140 |
Why?
|
| Humans | 17 | 2024 | 123258 | 0.140 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 202 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2019 | 221 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 187 | 0.140 |
Why?
|
| Proteins | 3 | 2008 | 1040 | 0.140 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 221 | 0.140 |
Why?
|
| Cell Line | 2 | 2021 | 2772 | 0.130 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 664 | 0.120 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 2478 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 576 | 0.110 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 165 | 0.110 |
Why?
|
| Neuroblastoma | 1 | 2019 | 519 | 0.110 |
Why?
|
| Genome, Human | 1 | 2021 | 1265 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2014 | 400 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 654 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2018 | 940 | 0.100 |
Why?
|
| Proteomics | 2 | 2006 | 479 | 0.100 |
Why?
|
| Binding Sites | 1 | 2014 | 1294 | 0.100 |
Why?
|
| Protein Structure, Secondary | 3 | 2008 | 239 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1591 | 0.090 |
Why?
|
| Algorithms | 3 | 2014 | 1598 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 454 | 0.090 |
Why?
|
| Gram-Negative Bacteria | 2 | 2007 | 67 | 0.090 |
Why?
|
| Dipeptides | 1 | 2008 | 59 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2011 | 334 | 0.070 |
Why?
|
| Sequence Alignment | 1 | 2007 | 623 | 0.060 |
Why?
|
| Mutation | 1 | 2018 | 5765 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 2008 | 1523 | 0.050 |
Why?
|
| Female | 5 | 2024 | 65619 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 878 | 0.050 |
Why?
|
| Relative Biological Effectiveness | 1 | 2021 | 6 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2023 | 667 | 0.050 |
Why?
|
| Radiation Tolerance | 1 | 2021 | 52 | 0.050 |
Why?
|
| Protons | 1 | 2021 | 91 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 374 | 0.050 |
Why?
|
| Carbon | 1 | 2021 | 92 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2023 | 263 | 0.040 |
Why?
|
| Wound Healing | 1 | 2024 | 452 | 0.040 |
Why?
|
| Phylogeny | 1 | 2022 | 694 | 0.040 |
Why?
|
| Gene Drive Technology | 1 | 2019 | 6 | 0.040 |
Why?
|
| Cell Survival | 1 | 2021 | 806 | 0.040 |
Why?
|
| SEER Program | 1 | 2019 | 194 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2008 | 2695 | 0.040 |
Why?
|
| K562 Cells | 1 | 2018 | 95 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 88 | 0.040 |
Why?
|
| RNA Precursors | 1 | 2018 | 67 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2018 | 184 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 126 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 3867 | 0.040 |
Why?
|
| Protein Domains | 1 | 2018 | 233 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2018 | 423 | 0.040 |
Why?
|
| United States | 2 | 2024 | 10652 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2018 | 172 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 216 | 0.030 |
Why?
|
| Inflammation | 1 | 2024 | 1405 | 0.030 |
Why?
|
| Probability | 2 | 2008 | 321 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2018 | 752 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2022 | 1753 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 1473 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3336 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 1070 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 4367 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 807 | 0.030 |
Why?
|
| Aged | 2 | 2024 | 19194 | 0.030 |
Why?
|
| Mice | 2 | 2024 | 17552 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 791 | 0.030 |
Why?
|
| Base Sequence | 1 | 2018 | 3091 | 0.030 |
Why?
|
| Male | 3 | 2024 | 60336 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 4296 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 26087 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 3053 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2018 | 989 | 0.020 |
Why?
|
| Software | 2 | 2006 | 675 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 8868 | 0.020 |
Why?
|
| Animals | 2 | 2024 | 33847 | 0.020 |
Why?
|
| Genomics | 1 | 2018 | 1474 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 2844 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 269 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2019 | 2586 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 4510 | 0.020 |
Why?
|
| Solubility | 1 | 2008 | 132 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1414 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3079 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 4499 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 16068 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 657 | 0.020 |
Why?
|
| Bacteriorhodopsins | 1 | 2006 | 3 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 569 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2006 | 37 | 0.020 |
Why?
|
| Solvents | 1 | 2006 | 42 | 0.020 |
Why?
|
| Protein Folding | 1 | 2006 | 218 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 29100 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2006 | 833 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2006 | 458 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2006 | 356 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2006 | 471 | 0.010 |
Why?
|
| Child | 1 | 2023 | 24259 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2006 | 631 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 2114 | 0.010 |
Why?
|
| Peptides | 1 | 2006 | 791 | 0.010 |
Why?
|